Principal Investigator Edward Adelson
Principal Investigator Sebastian Lourido
C Cem Tasan
Principal Investigator Tomas Lozano-Perez
Principal Investigator Elazer Edelman
AI’s influence is undeniable in the digital realm, affecting consumers’ lives and corporate operations. Transferring these advancements to sectors producing physical goods, such as drug discovery and biotech, commodity chemicals, materials for energy and sustainability, and manufacturing, presents a thrilling prospect and a translational challenge. This talk will explore the present use cases and the potential of applying generative AI within the chemistry and materials domain. Unlike a large part of the tech sector, these industries are capital-intensive and cautious, meaning that AI must bridge an “execution gap” between the digital and physical realms for value generation. We will outline strategies to overcome current technical and cultural hurdles.
Rosalind Picard Director, Affective Computing Group MIT Media Lab
Principal Investigator Yossi Sheffi
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.